Your browser doesn't support javascript.
loading
Statewide Implementation of Universal Third-Trimester Repeat HIV Testing in Illinois.
Yee, Lynn M; Ayala, Laurie D; Roach, Alexis M; Statton, Anne; Randhawa, Sukhdeep; Garcia, Patricia M; Miller, Emily S.
Afiliación
  • Yee LM; Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Ayala LD; 24/7 Illinois Perinatal HIV Hotline, Chicago, Illinois.
  • Roach AM; 24/7 Illinois Perinatal HIV Hotline, Chicago, Illinois.
  • Statton A; Mother and Child Alliance (MACA), Chicago, Illinois.
  • Randhawa S; Mother and Child Alliance (MACA), Chicago, Illinois.
  • Garcia PM; Mother and Child Alliance (MACA), Chicago, Illinois.
  • Miller ES; Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Am J Perinatol ; 41(3): 241-247, 2024 Feb.
Article en En | MEDLINE | ID: mdl-37852273
OBJECTIVE: This article aims to assess statewide uptake of HIV repeat testing in the first 2 years after the implementation of an amendment to the Illinois Perinatal HIV Prevention Act (IPHPA) mandating universal repeat HIV testing in the third trimester. STUDY DESIGN: This is a retrospective, population-based study of all birthing individuals in Illinois (2018-2019). Data were collected using the state-mandated closed system of perinatal HIV test reporting. We evaluated the incidence of mother-infant pairs with negative early tests and repeat third-trimester tests (RTTTs) performed in adherence with the law, as well as the timing of the performance of the RTTTs (outpatient vs. inpatient). Chi-square tests of trend by quarter were performed to ascertain sustainability. RESULTS: Of 138,805 individuals delivered in 2018, 80.6% presented with early test and RTTTs. In 2018, outpatient RTTTs improved from 71.8% (quarter 1) to 85.1% (quarter 4; p < 0.001). In 2018, the proportion of mother-infant dyads who received testing that was adherent to the IPHPA Amendment was 92.1, 95.5, 96.7, and 96.4% in quarters 1 through 4, respectively (p < 0.001). In 2019, outpatient RTTTs performance remained high (87.4%) and stable (p = 0.06). In 2019, 99.9% of mother-infant dyads had testing adherent to the mandate in quarters 1 through 4 (p = 0.39). Of individuals who presented without RTTTs, 93.5% (2018) and 98.8% (2019) underwent inpatient testing before delivery. CONCLUSION: Implementation of RTTTs in Illinois was rapid, successful, and sustained in its first 2 years. Public health methodologies from Illinois may benefit other states implementing RTTT programs. KEY POINTS: · In 2018, Illinois enacted statewide RTTT for HIV among all parturients.. · In 2019, over 99% of mother-infant dyads had documentation of both early and repeat HIV testing before hospital discharge.. · Implementation of repeat third-trimester HIV testing in Illinois was rapid, successful, and sustained in its first 2 years.. · Public health methodologies from Illinois may benefit other states implementing similar programs..
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por VIH / Prueba de VIH Límite: Female / Humans / Pregnancy País/Región como asunto: America do norte Idioma: En Revista: Am J Perinatol Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por VIH / Prueba de VIH Límite: Female / Humans / Pregnancy País/Región como asunto: America do norte Idioma: En Revista: Am J Perinatol Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos